Test Product: Durga Herbalix™ Phase 1 Massage Tincture (Lot Number Not Provided)
| Challenge Microorganism | ATCC # | Initial Population
(CFU/mL of Product) |
Days Following Inoculation | Log10 Reduction | Percent Reduction |
| Aspergillus niger | 16404 | 1.1425 x 107 | 7 | 6.0579 | 99.9999% |
| 14 | 6.0579 | 99.9999% | |||
| 28 | 6.0579 | 99.9999% | |||
| Candida albicans | 10231 | 9.750 x 105 | 7 | 4.9890 | 99.9990% |
| 14 | 4.9890 | 99.9990% | |||
| 28 | 4.9890 | 99.9990% | |||
| Escherichia coli | 8739 | 3.7250 x 105 | 7 | 4.5711 | 99.9973% |
| 14 | 4.5711 | 99.9973% | |||
| 28 | 4.5711 | 99.9973% | |||
| Pseudomonas aeruginosa | 9027 | 5.450 x 105 | 7 | 4.7364 | 99.9982% |
| 14 | 4.7364 | 99.9982% | |||
| 28 | 4.7364 | 99.9982% | |||
| Staphylococcus aureus | 6538 | 7.5250 x 105 | 7 | 4.8765 | 99.9987% |
| 14 | 4.8765 | 99.9987% | |||
| 28 | 4.8765 | 99.9987% |
Meets the following USP 29, NF 24, 2006 acceptance criteria for Category 2 Products (Topically used, aqueous based products): Bacteria should be reduced from the initial population by no less than 2.0 Log10 by Day 14, and should exhibit no increase in population from Day 14 at Day 28. Populations of yeast/mold should exhibit no increase from the initial calculated population at Day 14 or Day 28.